Abstract
A 21-year-old male presented to the emergency department with the history of rapidly progressive diminution of vision in his right eye associated with headache and pain with eye movement for 5 days. It was not associated with double vision, tingling, numbness, or weakness of his body parts. He did not give any history of preceding fever, rashes, joint pain, oral ulcers, or recent immunization. Best corrected visual acuity was 6/60 and 6/6 in right and left eye respectively with RAPD in the right eye. Rest of the anterior and posterior segment findings were normal. He was diagnosed as right optic neuritis and appropriate investigations were sent while starting treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shams P, Plant G. Optic neuritis: a review. Int MS J. 2009;16(3):82–9.
Pau D, Al Zubidi N, Yalamanchili S, Plant G, Lee AG. Optic neuritis. Eye. 2011;25(7):833.
Woung L-C, Chung H-C, Jou J-R, Wang K-C, Peng P-H. A comparison of optic neuritis in Asian and in Western countries. Neuro-ophthalmology. 2011;35(2):65–72.
Seah B, Tow S, Ong OK, Yang C, Tsai C, Lee K, et al. The natural history of optic neuritis in Asian patients: an observational cohort study. Neurol Asia. 2017;22(4):341–8.
Beck RW. The optic neuritis treatment trial. Arch Ophthalmol. 1988;106(8):1051–3.
Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 1991;109:1673–8.
Wakakura M, Minei-Higa R, Oono S, Matsui Y, Tabuchi A, Kani K, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol. 1999;43(2):127–32.
Wang JC, Tow S, Aung T, Lim SA, Cullen JF. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Exp Ophthalmol. 2001;29(5):312–5.
Ratchford J, Quigg M, Conger A, Frohman T, Frohman E, Balcer L, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73(4):302–8.
Beck RW, Trobe JD, Optic Neuritis Study Group. What we have learned from the optic neuritis treatment trial. Ophthalmology. 1995;102(10):1504–8.
O'Connor P. The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: a post hoc analysis of data from CHAMPS. Clin Ther. 2003;25(11):2865–74.
Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernández O, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001;357(9268):1576–82.
Kappos L, Polman C, Freedman M, Edan G, Hartung H, Miller D, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology. 2006;67(7):1242–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sitaula, S. (2024). Optic Neuritis. In: Oli, K.K., Shrestha, G.S., Ojha, R., Pal, P.K., Pandey, S., Das, B. (eds) Case-based Approach to Common Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-8676-7_22
Download citation
DOI: https://doi.org/10.1007/978-981-99-8676-7_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8675-0
Online ISBN: 978-981-99-8676-7
eBook Packages: MedicineMedicine (R0)